Doctors, drugmakers call for broader scope of marketing activities

Published: 2013-04-23 06:58:00

Updated: 2013-04-23 06:58:00

Doctors and pharmaceutical companies have recently called on the government to revise regulations relating to the system that they called ”ambiguous“ in distinguishing between legal and illegal marketing acts.

In a forum hosted by the Korean Medical Association (KMA) on Friday, a local lawyer ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK